HTA Glossary

Net monetary benefit (NMB)

Net monetary benefit (NMB) expresses the result of an economic evaluation in money: the health gain from a technology is multiplied by the willingness-to-pay threshold, and the cost is subtracted. A positive incremental net monetary benefit means that the technology is cost-effective at that threshold.

By HTA Course · Last reviewed

In more detail

NMB explained

A hypothetical example: a new treatment adds 1.0 QALY and £30,000 in cost. At a threshold of £35,000 per QALY the incremental net monetary benefit is £35,000 minus £30,000, or +£5,000, so it is cost-effective. At £25,000 per QALY the result is −£5,000, so it is not.

Net monetary benefit avoids the problems of a ratio. It stays meaningful when a technology dominates or is dominated, and with several options the best one is simply the option with the highest net monetary benefit. For this reason it is widely used in probabilistic sensitivity analysis and to draw cost-effectiveness acceptability curves.

Net health benefit is the same idea expressed in health units: the health gained minus the cost divided by the threshold. Both measures depend on the threshold chosen, so results are usually shown for a range of values.

Formula

NMB formula

Incremental NMB = (incremental effect × threshold) − incremental cost

Effect in QALYs, threshold in money per QALY. A result above zero means cost-effective at that threshold.

Go further

Learn HTA from A to Z

The HTA Course puts this term in context, with worked examples and interactive lessons across 15 modules and 79 self-paced lessons, and a certificate of completion.